You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Cancer Research UK partners with Aleta Biotherapeutics on blood cancer therapy

Cancer Research UK (CRUK) and biotech company Aleta Biotherapeutics have entered into a collaboration on the early phase clinical development of Aleta’s blood cancer therapy candidate ALETA-001.